 Amy Huebschmann
Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 17 | 2023 | 2442 | 1.910 |
Why?
| | Exercise | 14 | 2024 | 1928 | 1.830 |
Why?
| | School Health Services | 4 | 2024 | 234 | 1.800 |
Why?
| | Asthma | 5 | 2024 | 2225 | 1.440 |
Why?
| | Primary Health Care | 14 | 2025 | 1686 | 1.310 |
Why?
| | Contraception | 2 | 2021 | 153 | 1.030 |
Why?
| | Health Equity | 2 | 2025 | 87 | 1.010 |
Why?
| | Mass Screening | 6 | 2025 | 1190 | 0.920 |
Why?
| | Community-Institutional Relations | 1 | 2025 | 95 | 0.910 |
Why?
| | Community-Based Participatory Research | 1 | 2025 | 148 | 0.860 |
Why?
| | Chest Pain | 1 | 2024 | 88 | 0.850 |
Why?
| | School Nursing | 1 | 2024 | 30 | 0.850 |
Why?
| | Qualitative Research | 7 | 2024 | 1219 | 0.850 |
Why?
| | Diabetes Mellitus | 5 | 2020 | 1001 | 0.840 |
Why?
| | Telemedicine | 2 | 2021 | 792 | 0.770 |
Why?
| | Motivation | 2 | 2018 | 547 | 0.770 |
Why?
| | Cardiovascular Diseases | 5 | 2023 | 2006 | 0.730 |
Why?
| | Early Detection of Cancer | 1 | 2025 | 370 | 0.700 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2025 | 1365 | 0.700 |
Why?
| | Mentoring | 2 | 2024 | 128 | 0.690 |
Why?
| | Self-Management | 2 | 2019 | 163 | 0.680 |
Why?
| | Research Design | 4 | 2022 | 1045 | 0.650 |
Why?
| | Couples Therapy | 1 | 2019 | 13 | 0.650 |
Why?
| | Counseling | 2 | 2014 | 386 | 0.650 |
Why?
| | Humans | 67 | 2025 | 129627 | 0.640 |
Why?
| | Health Behavior | 4 | 2024 | 743 | 0.610 |
Why?
| | Postpartum Period | 1 | 2021 | 333 | 0.590 |
Why?
| | Information Dissemination | 2 | 2023 | 205 | 0.570 |
Why?
| | Sex Factors | 5 | 2024 | 1970 | 0.540 |
Why?
| | Hair | 1 | 2015 | 73 | 0.480 |
Why?
| | Reproducibility of Results | 2 | 2022 | 3080 | 0.470 |
Why?
| | Caregivers | 5 | 2024 | 806 | 0.470 |
Why?
| | Social Determinants of Health | 4 | 2024 | 226 | 0.460 |
Why?
| | Female | 35 | 2024 | 68735 | 0.450 |
Why?
| | Surveys and Questionnaires | 10 | 2024 | 5415 | 0.450 |
Why?
| | Patients | 3 | 2020 | 169 | 0.450 |
Why?
| | Athletes | 1 | 2018 | 411 | 0.440 |
Why?
| | Health Promotion | 3 | 2021 | 720 | 0.420 |
Why?
| | Needs Assessment | 3 | 2024 | 357 | 0.420 |
Why?
| | Biomarkers | 1 | 2024 | 3968 | 0.410 |
Why?
| | Professional-Patient Relations | 2 | 2012 | 138 | 0.410 |
Why?
| | Biomedical Research | 1 | 2019 | 640 | 0.400 |
Why?
| | Delivery of Health Care | 5 | 2022 | 898 | 0.400 |
Why?
| | Aged | 19 | 2024 | 22061 | 0.400 |
Why?
| | Lung Neoplasms | 1 | 2025 | 2342 | 0.390 |
Why?
| | Hypertension | 4 | 2022 | 1243 | 0.380 |
Why?
| | Aging, Premature | 1 | 2011 | 13 | 0.370 |
Why?
| | Interviews as Topic | 4 | 2024 | 704 | 0.370 |
Why?
| | Healthcare Disparities | 1 | 2018 | 578 | 0.370 |
Why?
| | Colorado | 7 | 2024 | 4404 | 0.370 |
Why?
| | Middle Aged | 23 | 2024 | 31136 | 0.360 |
Why?
| | Critical Pathways | 1 | 2012 | 84 | 0.350 |
Why?
| | Patient Preference | 2 | 2024 | 184 | 0.350 |
Why?
| | Male | 28 | 2024 | 63671 | 0.340 |
Why?
| | Dietary Fats | 1 | 2012 | 301 | 0.330 |
Why?
| | Medicare | 4 | 2022 | 708 | 0.310 |
Why?
| | Perception | 2 | 2024 | 344 | 0.310 |
Why?
| | Disease Management | 2 | 2015 | 588 | 0.310 |
Why?
| | Feasibility Studies | 3 | 2022 | 869 | 0.310 |
Why?
| | Occupational Health | 2 | 2022 | 192 | 0.310 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2024 | 1280 | 0.300 |
Why?
| | Physical Exertion | 1 | 2009 | 205 | 0.300 |
Why?
| | Practice Patterns, Physicians' | 2 | 2014 | 1271 | 0.290 |
Why?
| | Adult | 23 | 2024 | 35600 | 0.290 |
Why?
| | Attitude of Health Personnel | 2 | 2024 | 1098 | 0.290 |
Why?
| | Diabetic Angiopathies | 3 | 2017 | 261 | 0.290 |
Why?
| | Fear | 1 | 2011 | 354 | 0.290 |
Why?
| | Social Support | 3 | 2024 | 584 | 0.250 |
Why?
| | Glycation End Products, Advanced | 1 | 2006 | 76 | 0.240 |
Why?
| | United States | 11 | 2025 | 13871 | 0.240 |
Why?
| | Physicians | 3 | 2023 | 866 | 0.240 |
Why?
| | Vascular Stiffness | 2 | 2023 | 467 | 0.240 |
Why?
| | Adolescent | 10 | 2024 | 20412 | 0.240 |
Why?
| | Chronic Disease | 4 | 2024 | 1720 | 0.240 |
Why?
| | Electronic Health Records | 2 | 2024 | 973 | 0.230 |
Why?
| | Point-of-Care Systems | 2 | 2020 | 148 | 0.230 |
Why?
| | Troponin | 1 | 2024 | 50 | 0.230 |
Why?
| | Troponin T | 1 | 2024 | 57 | 0.220 |
Why?
| | Narration | 1 | 2024 | 57 | 0.220 |
Why?
| | Troponin I | 1 | 2024 | 75 | 0.220 |
Why?
| | Transportation | 1 | 2024 | 50 | 0.210 |
Why?
| | Social Isolation | 1 | 2024 | 59 | 0.210 |
Why?
| | Vulnerable Populations | 1 | 2024 | 156 | 0.210 |
Why?
| | Oxygen | 2 | 2018 | 915 | 0.200 |
Why?
| | Cross-Sectional Studies | 8 | 2021 | 5075 | 0.200 |
Why?
| | Mental Health | 3 | 2024 | 688 | 0.200 |
Why?
| | Peer Group | 1 | 2024 | 227 | 0.190 |
Why?
| | Hospice and Palliative Care Nursing | 1 | 2023 | 71 | 0.190 |
Why?
| | Leg | 2 | 2021 | 239 | 0.180 |
Why?
| | Child | 9 | 2024 | 20884 | 0.180 |
Why?
| | Government Programs | 1 | 2021 | 22 | 0.180 |
Why?
| | Heart Failure | 3 | 2023 | 2133 | 0.180 |
Why?
| | Health Care Surveys | 2 | 2014 | 557 | 0.180 |
Why?
| | Home Care Services | 1 | 2023 | 225 | 0.170 |
Why?
| | Contraceptive Agents | 1 | 2021 | 65 | 0.170 |
Why?
| | Oxygen Consumption | 6 | 2021 | 672 | 0.170 |
Why?
| | Decision Support Systems, Clinical | 1 | 2023 | 205 | 0.170 |
Why?
| | Oxidative Phosphorylation | 2 | 2019 | 188 | 0.170 |
Why?
| | Patient Navigation | 1 | 2022 | 78 | 0.170 |
Why?
| | Multiple Chronic Conditions | 1 | 2020 | 28 | 0.170 |
Why?
| | Precision Medicine | 1 | 2024 | 387 | 0.170 |
Why?
| | Guatemala | 1 | 2021 | 313 | 0.170 |
Why?
| | Dementia | 1 | 2023 | 225 | 0.170 |
Why?
| | Pilot Projects | 3 | 2024 | 1592 | 0.170 |
Why?
| | Palliative Care | 2 | 2023 | 702 | 0.160 |
Why?
| | Social Welfare | 1 | 2019 | 26 | 0.160 |
Why?
| | Cancer Survivors | 1 | 2024 | 257 | 0.160 |
Why?
| | Influenza Vaccines | 1 | 2024 | 532 | 0.160 |
Why?
| | Health Personnel | 2 | 2024 | 653 | 0.160 |
Why?
| | Social Work | 1 | 2020 | 83 | 0.160 |
Why?
| | Psychosocial Support Systems | 1 | 2019 | 13 | 0.160 |
Why?
| | Community Mental Health Services | 1 | 2020 | 89 | 0.160 |
Why?
| | Socioeconomic Factors | 2 | 2015 | 1213 | 0.160 |
Why?
| | Intimate Partner Violence | 1 | 2021 | 84 | 0.160 |
Why?
| | Patient Care Planning | 1 | 2020 | 146 | 0.160 |
Why?
| | Sitagliptin Phosphate | 1 | 2019 | 32 | 0.160 |
Why?
| | Diastole | 1 | 2019 | 148 | 0.150 |
Why?
| | Patient Care Team | 2 | 2022 | 600 | 0.150 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 46 | 0.150 |
Why?
| | Cardiorespiratory Fitness | 1 | 2019 | 49 | 0.150 |
Why?
| | Accelerometry | 1 | 2019 | 93 | 0.150 |
Why?
| | Inpatients | 1 | 2023 | 475 | 0.150 |
Why?
| | Schools | 1 | 2022 | 443 | 0.150 |
Why?
| | Influenza, Human | 1 | 2024 | 601 | 0.150 |
Why?
| | Exercise Tolerance | 2 | 2017 | 273 | 0.150 |
Why?
| | Focus Groups | 2 | 2023 | 450 | 0.150 |
Why?
| | Health Services Accessibility | 2 | 2024 | 903 | 0.140 |
Why?
| | Cardiovascular System | 1 | 2019 | 136 | 0.140 |
Why?
| | Cultural Characteristics | 1 | 2018 | 63 | 0.140 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2017 | 62 | 0.140 |
Why?
| | Health Care Costs | 1 | 2020 | 367 | 0.140 |
Why?
| | Checklist | 1 | 2018 | 93 | 0.140 |
Why?
| | Hypoglycemic Agents | 3 | 2019 | 1221 | 0.140 |
Why?
| | Ultrasonography | 1 | 2020 | 712 | 0.130 |
Why?
| | Patient Satisfaction | 2 | 2019 | 633 | 0.130 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 111 | 0.130 |
Why?
| | Research Personnel | 1 | 2018 | 156 | 0.130 |
Why?
| | Venoms | 1 | 2016 | 29 | 0.130 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2016 | 34 | 0.130 |
Why?
| | Microvessels | 1 | 2017 | 82 | 0.130 |
Why?
| | Muscle, Skeletal | 4 | 2021 | 1613 | 0.130 |
Why?
| | Vaccination | 1 | 2024 | 1347 | 0.130 |
Why?
| | Self Efficacy | 1 | 2019 | 377 | 0.130 |
Why?
| | Lung Diseases | 1 | 2022 | 741 | 0.120 |
Why?
| | Blood Vessels | 1 | 2017 | 187 | 0.120 |
Why?
| | Sex Characteristics | 2 | 2022 | 736 | 0.120 |
Why?
| | Quality Improvement | 1 | 2023 | 1101 | 0.120 |
Why?
| | Risk Factors | 3 | 2020 | 9786 | 0.110 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 761 | 0.110 |
Why?
| | American Heart Association | 1 | 2015 | 300 | 0.110 |
Why?
| | Aged, 80 and over | 2 | 2024 | 7052 | 0.110 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2016 | 385 | 0.100 |
Why?
| | Faculty | 1 | 2014 | 137 | 0.100 |
Why?
| | Pandemics | 1 | 2021 | 1491 | 0.100 |
Why?
| | Prospective Studies | 3 | 2021 | 7135 | 0.100 |
Why?
| | Incidence | 1 | 2019 | 2641 | 0.100 |
Why?
| | Prevalence | 1 | 2019 | 2564 | 0.100 |
Why?
| | Interprofessional Relations | 1 | 2015 | 277 | 0.100 |
Why?
| | Pharmacists | 1 | 2015 | 246 | 0.100 |
Why?
| | Cooperative Behavior | 1 | 2015 | 433 | 0.100 |
Why?
| | Attitude to Health | 1 | 2015 | 433 | 0.100 |
Why?
| | Breast Neoplasms | 1 | 2024 | 2133 | 0.100 |
Why?
| | Internal Medicine | 1 | 2014 | 242 | 0.090 |
Why?
| | Women's Health | 1 | 2014 | 364 | 0.090 |
Why?
| | Psychotherapy | 1 | 2012 | 158 | 0.090 |
Why?
| | Peptides | 1 | 2016 | 926 | 0.090 |
Why?
| | Dietary Carbohydrates | 1 | 2012 | 151 | 0.090 |
Why?
| | Exercise Test | 2 | 2015 | 613 | 0.090 |
Why?
| | Antidepressive Agents | 1 | 2012 | 229 | 0.090 |
Why?
| | Plant Preparations | 1 | 2010 | 32 | 0.080 |
Why?
| | Health Expenditures | 1 | 2012 | 180 | 0.080 |
Why?
| | Nonprescription Drugs | 1 | 2010 | 66 | 0.080 |
Why?
| | Workplace | 2 | 2022 | 247 | 0.080 |
Why?
| | Depressive Disorder | 1 | 2012 | 367 | 0.080 |
Why?
| | Pulse Wave Analysis | 2 | 2023 | 248 | 0.080 |
Why?
| | Obesity | 2 | 2023 | 2882 | 0.080 |
Why?
| | Comparative Effectiveness Research | 1 | 2010 | 150 | 0.080 |
Why?
| | Patient Education as Topic | 1 | 2014 | 737 | 0.080 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 485 | 0.070 |
Why?
| | Patient Compliance | 1 | 2012 | 565 | 0.070 |
Why?
| | Guideline Adherence | 1 | 2012 | 527 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2011 | 0.070 |
Why?
| | Prejudice | 1 | 2007 | 70 | 0.070 |
Why?
| | Follow-Up Studies | 2 | 2016 | 4894 | 0.070 |
Why?
| | Diabetes, Gestational | 1 | 2011 | 308 | 0.070 |
Why?
| | Disclosure | 1 | 2007 | 110 | 0.070 |
Why?
| | Walking | 1 | 2011 | 500 | 0.070 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2006 | 31 | 0.060 |
Why?
| | Medicaid | 2 | 2019 | 431 | 0.060 |
Why?
| | Hypoglycemia | 1 | 2010 | 427 | 0.060 |
Why?
| | Mothers | 1 | 2011 | 731 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2006 | 217 | 0.060 |
Why?
| | Age Factors | 1 | 2012 | 3152 | 0.060 |
Why?
| | Internship and Residency | 1 | 2014 | 1050 | 0.060 |
Why?
| | Regional Blood Flow | 2 | 2017 | 463 | 0.050 |
Why?
| | Safety-net Providers | 1 | 2024 | 110 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2019 | 1875 | 0.050 |
Why?
| | Delphi Technique | 1 | 2024 | 226 | 0.050 |
Why?
| | Patient Care | 1 | 2023 | 108 | 0.050 |
Why?
| | Aging | 1 | 2011 | 1778 | 0.050 |
Why?
| | Longevity | 1 | 2022 | 155 | 0.040 |
Why?
| | Aorta, Thoracic | 1 | 2023 | 263 | 0.040 |
Why?
| | Small Business | 1 | 2021 | 51 | 0.040 |
Why?
| | Point-of-Care Testing | 1 | 2020 | 32 | 0.040 |
Why?
| | Stroke Volume | 1 | 2023 | 592 | 0.040 |
Why?
| | Internet | 1 | 2024 | 618 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 540 | 0.040 |
Why?
| | Sulfonylurea Compounds | 1 | 2019 | 46 | 0.040 |
Why?
| | Self Care | 1 | 2022 | 363 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1724 | 0.040 |
Why?
| | Placebos | 1 | 2019 | 201 | 0.040 |
Why?
| | Goals | 1 | 2020 | 159 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 531 | 0.040 |
Why?
| | Young Adult | 2 | 2012 | 12455 | 0.040 |
Why?
| | Emergency Service, Hospital | 2 | 2019 | 1914 | 0.040 |
Why?
| | Poverty | 1 | 2022 | 499 | 0.040 |
Why?
| | Consensus | 1 | 2021 | 618 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2022 | 514 | 0.040 |
Why?
| | Cell Respiration | 1 | 2018 | 98 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 97 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2012 | 10219 | 0.030 |
Why?
| | Capillary Resistance | 1 | 2017 | 5 | 0.030 |
Why?
| | Oxyhemoglobins | 1 | 2017 | 21 | 0.030 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2017 | 48 | 0.030 |
Why?
| | Microcirculation | 1 | 2017 | 145 | 0.030 |
Why?
| | Publishing | 1 | 2018 | 140 | 0.030 |
Why?
| | Health Status | 1 | 2021 | 756 | 0.030 |
Why?
| | Bicycling | 1 | 2017 | 116 | 0.030 |
Why?
| | Communication | 1 | 2022 | 838 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2017 | 371 | 0.030 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2016 | 114 | 0.030 |
Why?
| | Infant | 2 | 2024 | 8995 | 0.030 |
Why?
| | Parents | 1 | 2024 | 1316 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1034 | 0.030 |
Why?
| | Hemoglobins | 1 | 2017 | 339 | 0.030 |
Why?
| | Ventricular Function | 1 | 2015 | 61 | 0.030 |
Why?
| | Child, Preschool | 2 | 2024 | 10490 | 0.030 |
Why?
| | Arteries | 1 | 2016 | 265 | 0.030 |
Why?
| | Forearm | 1 | 2015 | 117 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1266 | 0.030 |
Why?
| | Endothelium | 1 | 2015 | 121 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 108 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2015 | 201 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2720 | 0.030 |
Why?
| | Blood Pressure | 1 | 2021 | 1736 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2018 | 412 | 0.030 |
Why?
| | Brachial Artery | 1 | 2015 | 192 | 0.030 |
Why?
| | Reaction Time | 1 | 2015 | 417 | 0.030 |
Why?
| | Lung Diseases, Obstructive | 1 | 2012 | 46 | 0.020 |
Why?
| | Pediatrics | 1 | 2020 | 1056 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 2688 | 0.020 |
Why?
| | Vasodilation | 1 | 2015 | 476 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2016 | 781 | 0.020 |
Why?
| | Kinetics | 1 | 2015 | 1645 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3262 | 0.020 |
Why?
| | Mexico | 1 | 2011 | 191 | 0.020 |
Why?
| | Computer Communication Networks | 1 | 2010 | 32 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2016 | 903 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2015 | 730 | 0.020 |
Why?
| | Blood Glucose | 1 | 2019 | 2100 | 0.020 |
Why?
| | Emigrants and Immigrants | 1 | 2011 | 122 | 0.020 |
Why?
| | Mental Health Services | 1 | 2012 | 404 | 0.020 |
Why?
| | Comorbidity | 1 | 2012 | 1547 | 0.020 |
Why?
| | Homosexuality, Female | 1 | 2007 | 39 | 0.020 |
Why?
| | Logistic Models | 1 | 2012 | 1986 | 0.020 |
Why?
| | Public Opinion | 1 | 2007 | 64 | 0.020 |
Why?
| | Models, Statistical | 1 | 2011 | 625 | 0.020 |
Why?
| | Data Collection | 1 | 2010 | 650 | 0.020 |
Why?
| | Homosexuality, Male | 1 | 2007 | 176 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2015 | 1167 | 0.020 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 679 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2012 | 14522 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 6417 | 0.010 |
Why?
|
|
Huebschmann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|